Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

VL-0395

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
In this phase of structure-affinity relationship study of VL-0395, a new anthranilic acid based CCK1 selective antagonist, we… Expand
2005
2005
Starting from our lead compound, VL-0395, an anthranilic acid based CCK1 receptor antagonist, and following the well established… Expand
2004
2004
Recently we described an innovative class of non-peptide CCK(1) antagonists keeping appropriate pharmacophoric groups on the… Expand
2003
2003
Having successfully obtained new CCK(1) ligands holding appropriate groups on the anthranilic acid dimer used as molecular… Expand